Skip to main content
Browse Schedule
Browse by Day
Browse by Track
Browse by Topic
Featured Programming
Browse Faculty
Posters
Browse Full Listing
Browse by Author
Browse by Topic
Browse by Track
Best Practices Award Posters
Federal Forum Posters
Fellows Posters
Professional Posters
Resident Posters
Student Posters
My Stuff
ASHP LIVE! App
ASHP Privacy Policy
ASHP Terms & Conditions
Toggle navigation
Login
Search
Home
Browse Schedule
Browse by Day
Browse by Track
Browse by Topic
Featured Programming
Browse Faculty
Posters
Browse Full Listing
Browse by Author
Browse by Topic
Browse by Track
Best Practices Award Posters
Federal Forum Posters
Fellows Posters
Professional Posters
Resident Posters
Student Posters
My Stuff
ASHP LIVE! App
ASHP Privacy Policy
ASHP Terms & Conditions
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
195 Views
Favorite
0
Like
Facebook
Tweet
Federal Forum
(1-285) Evaluation of Prescribing Trends for Newly Approved Naloxone HCl Nasal Spray 8mg (Kloxxado™) to Naloxone HCl Nasal Spray 4mg (Narcan®) to Prevent Opioid Overdose
Sunday, December 4, 2022
3:30 PM – 5:00 PM
Location: Bayside A, Level 1
Category:
Research-in-Progress
Topic:
Psychiatry/Neurology
Co-Author(s):
Madeline Salsman, Monica Barrett, Olivia Howard
Primary Author(s)
Sean Blaeser, PharmD
PGY1 Pharmacy Resident
VA TVHS, Tennessee
